You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in Branded Drug CARDINAL HEALTH ANTISEPTIC SKIN CLEANSER


✉ Email this page to a colleague

« Back to Dashboard


Excipients Strategy and Commercial Opportunities for Cardinal Health Antiseptic Skin Cleanser

Last updated: February 27, 2026

What Is the Composition and Excipient Strategy?

Cardinal Health Antiseptic Skin Cleanser primarily contains active ingredients like chlorhexidine gluconate. The excipient profile supports efficacy, stability, and user experience. Core excipients include:

  • Carbomer or similar thickening agents: Enhance viscosity for ease of application.
  • Preservatives: Maintain microbial stability; parabens or similar agents are common.
  • Humectants: Glycerin to prevent skin dryness.
  • pH buffers: Ensure formulation stability and skin compatibility.
  • Water: solvent base for aqueous formulations.

Excipient selection aims to optimize antimicrobial efficacy, prolong shelf life, and ensure skin tolerability. Formulation adjustments focus on reducing irritation while maintaining product stability.

How Do Excipients Impact Key Product Attributes?

  • Stability: Preservatives prevent microbial growth; pH buffers stabilize active ingredients.
  • Efficacy: Viscosity modifiers improve application, increasing contact time.
  • Skin Compatibility: Humectants reduce irritation; non-irritating preservatives suitable for sensitive skin.
  • Shelf Life: Water activity and preservative efficacy extend product shelf life.

What Are the Commercial Opportunities in Excipient Innovation?

1. Enhanced Formulation Stability

  • Incorporating novel preservative systems (e.g., parabens-free alternatives) meets regulatory trends, appealing to consumer segments with sensitivities.
  • Use of advanced pH buffers improves overall product stability and reduces microbial contamination risk.

2. Improved Skin Tolerance

  • Introducing skin conditioners like niacinamide can enhance skin tolerability.
  • Developing alcohol-free or reduced-alcohol formulations broadens market access, especially for sensitive skin.

3. Sustainability and Clean Label Movement

  • Replacing synthetic excipients with plant-derived, biodegradable options aligns with consumer demand.
  • Transparent labeling of excipients, emphasizing natural or hypoallergenic ingredients, supports premium positioning.

4. Delivery and User Experience Innovations

  • Emollient-containing formulations improve user comfort.
  • Packaging innovations, such as pump bottles with dosing controls, enhance usability and reduce waste.

5. Regulatory and Market Trends

  • Regulatory bodies push for excipient safety, especially for products indicated for frequent use.
  • There is increasing demand for preservative-free solutions, creating opportunities for preservative alternatives and novel stabilizers.

What Are the R&D and Market Challenges?

  • Balancing antimicrobial efficacy with skin tolerability requires careful excipient selection.
  • Regulatory approvals for new excipients or preservative systems involve lengthy evaluations.
  • Market competition with established antiseptic brands necessitates differentiated formulations.

What Are the Revenue and Market Outlooks?

  • The global antiseptic skin care market was valued at approximately USD 6.8 billion in 2022 and is projected to grow at a CAGR of 6.2% through 2030 [1].
  • The North American market remains dominant, with innovation in excipient formulations serving as a key differentiator.
  • Private label and hospital procurement strategies favor formulations with proven stability, safety, and low irritation profiles.

Summary of Key Opportunities

Opportunity Area Description
Preservative alternatives Explore parabens-free and natural preservatives
Skin compatibility improvements Use of humectants, emollients, and soothing agents
Packaging innovations Dosing control, sustainable materials
Natural and biodegradable excipients Meet clean-label consumer preferences
Formulation stability enhancements Advanced buffers, enhanced preservative systems

Key Takeaways

  • Excipients in Cardinal Health Antiseptic Skin Cleanser influence stability, efficacy, tolerability, and user experience.
  • Innovation opportunities include preservative-free formulations, natural excipients, and enhanced delivery systems.
  • The growing antiseptic market favors formulations that balance antimicrobial efficacy with skin compatibility.
  • Regulatory shifts push for safer, more transparent excipient profiles.

FAQs

1. What excipients are essential for the stability of antiseptic skin cleansers?
Preservatives and pH buffers are critical for microbial stability and active ingredient stabilization.

2. How can excipient selection improve skin tolerability?
Incorporating humectants like glycerin and soothing agents such as niacinamide reduces irritation, especially for sensitive skin.

3. What trends influence excipient choices in antiseptic products?
Clean-label movement, demand for preservative-free products, and regulatory safety standards drive innovation.

4. Are natural excipients commercially viable in antiseptic formulations?
Yes, though they require rigorous testing; they appeal to health-conscious consumers and support premium branding.

5. How does formulation stability impact the commercial success of antiseptic cleansers?
Stable formulations have longer shelf life, maintain efficacy, and meet regulatory standards, supporting broader market acceptance.


References:

[1] MarketResearch.com. (2023). Global antiseptic skin care market forecast 2022-2030.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.